National Cancer Institute

Lantern Pharma cancer

Lantern Pharma Teams Up with National Cancer Institute to Predict Drug Effectiveness on Tumors

by | Oct 7, 2019
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
MORE
Beat AML
Simmons Cancer Center Joins Beat AML Trial
by | Jun 16, 2017
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern is one of 12 NCI-designated in the Beat AML trial, and the only site in Texas
MORE